Overview
Brian Mulherin is a Hematologist Oncology specialist and an Oncologist in Logansport, Indiana. Dr. Mulherin is rated as a Distinguished provider by MediFind in the treatment of Erythromelalgia. His top areas of expertise are Erythromelalgia, Paroxysmal Cold Hemoglobinuria, Paroxysmal Nocturnal Hemoglobinuria (PNH), Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration. Dr. Mulherin is currently accepting new patients.
His clinical research consists of co-authoring 7 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- EPO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MANAGED MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1025 Michigan Ave, Suite 15, Logansport, IN 46947
8301 Harcourt Rd, Suite 200, Indianapolis, IN 46260
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AnemiaDr. Mulherin isDistinguished. Learn about Anemia.
- Childhood Iron Deficiency AnemiaDr. Mulherin isDistinguished. Learn about Childhood Iron Deficiency Anemia.
- Chronic Lymphocytic Leukemia (CLL)Dr. Mulherin isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Colorectal CancerDr. Mulherin isDistinguished. Learn about Colorectal Cancer.
- ErythromelalgiaDr. Mulherin isDistinguished. Learn about Erythromelalgia.
- Familial Colorectal CancerDr. Mulherin isDistinguished. Learn about Familial Colorectal Cancer.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Breast CancerDr. Mulherin isAdvanced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Dr. Mulherin isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Mulherin isAdvanced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Drug-Induced ThrombocytopeniaDr. Mulherin isAdvanced. Learn about Drug-Induced Thrombocytopenia.
- EGFR Positive Lung CancerDr. Mulherin isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Mulherin isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Acute Eosinophilic PneumoniaDr. Mulherin isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Mulherin isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with MaturationDr. Mulherin isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Mulherin isExperienced. Learn about Acute Myeloid Leukemia (AML).